{"id":111545,"date":"2021-04-14T09:00:00","date_gmt":"2021-04-14T09:00:00","guid":{"rendered":"https:\/\/icrowdnewswire.com\/?p=2861620"},"modified":"2021-04-14T09:00:00","modified_gmt":"2021-04-14T09:00:00","slug":"growing-at-an-annualized-rate-of-12-the-hpapi-and-cytotoxic-drugs-contract-manufacturing-market-is-projected-to-reach-usd-25-billion-by-2030-claims-roots-analysis-3","status":"publish","type":"post","link":"http:\/\/ipsnews.net\/business\/2021\/04\/14\/growing-at-an-annualized-rate-of-12-the-hpapi-and-cytotoxic-drugs-contract-manufacturing-market-is-projected-to-reach-usd-25-billion-by-2030-claims-roots-analysis-3\/","title":{"rendered":"Growing at an annualized rate of 12%, the HPAPI and cytotoxic drugs contract manufacturing market is projected to reach USD 25 billion by 2030, claims Roots Analysis"},"content":{"rendered":"<p><img decoding=\"async\" width=\"273\" height=\"260\" src=\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/03\/4671-2693955i1UqqvJa.png\" class=\"webfeedsFeaturedVisual wp-post-image\" alt=\"\" loading=\"lazy\" style=\"display: block; margin-bottom: 5px; clear:both;max-width: 100%;\" link_thumbnail=\"\" \/><\/p>\n<p><em>Manufacturing highly potent drug products is technically and financially demanding; as a result, drug manufacturers are becoming increasingly reliant on contract service providers<\/em><\/p>\n<p><a href=\"https:\/\/www.rootsanalysis.com\/\">Roots Analysis<\/a> is pleased to announce the publication of its recent study, titled, &ldquo;<a href=\"https:\/\/www.rootsanalysis.com\/reports\/view_document\/hpapi-and-cytotoxic-drugs-manufacturing\/299.html\">HPAPI and Cytotoxic Drugs Manufacturing<\/a> (3rd Edition) 2020-2030.&rdquo;<\/p>\n<p>The report features an extensive study of the current market landscape and future opportunities associated with the contract manufacturing of HPAPIs and cytotoxic drugs. The study also features a detailed analysis of the key drivers and trends related to this evolving domain. In addition to other elements, the study includes:<\/p>\n<ul>\n<li>A detailed assessment of the current market landscape of companies offering contract services for manufacturing HPAPIs and cytotoxic drugs.<\/li>\n<li>A competitiveness analysis of HPAPI and cytotoxic drugs contract manufacturers, featuring insightful representations.<\/li>\n<li>Detailed profiles of leading contract manufacturers of HPAPI and cytotoxic drugs&nbsp;(<em>shortlisted on the basis of proprietary criterion<\/em>)<em>.<\/em><\/li>\n<li>An analysis of the partnerships that have been established in this domain, in the recent past.<\/li>\n<li>An analysis of the various expansion initiatives undertaken by the players in this domain.<\/li>\n<li>An estimate of the overall, installed capacity for manufacturing HPAPIs and cytotoxic drugs based on data reported by industry stakeholders in the public domain.<\/li>\n<li>A qualitative analysis to decide whether to manufacture the potent products in-house or engage the services of a CMO.<\/li>\n<li>A discussion on affiliated trends, key drivers and challenges which are likely to impact the industry&rsquo;s evolution.<\/li>\n<li>A case study on the antibody drug conjugates (ADCs) manufacturing market, highlighting a list of contract service providers and in-house manufacturers in this domain.<\/li>\n<li>A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)\n<ul>\n<li>Type of Product<\/li>\n<\/ul>\n<\/li>\n<li>HPAPIs<\/li>\n<li>Highly Potent Finished Dosage Forms<\/li>\n<\/ul>\n<p>Company Size<\/p>\n<ul>\n<li>Small-sized<\/li>\n<li>Mid-sized<\/li>\n<li>Large \/ Very Large<\/li>\n<\/ul>\n<p>Scale of Operation<\/p>\n<ul>\n<li>Preclinical \/ Clinical<\/li>\n<li>Commercial<\/li>\n<\/ul>\n<p>Type of Pharmacological Molecule<\/p>\n<ul>\n<li>Small Molecules<\/li>\n<li>Biologics<\/li>\n<\/ul>\n<p>Type of Highly Potent Finished Dosage Form<\/p>\n<ul>\n<li>Injectables<\/li>\n<li>Oral Solids<\/li>\n<li>Creams<\/li>\n<li>Others\n<ul>\n<li>Key geographical regions<\/li>\n<\/ul>\n<\/li>\n<li>North America<\/li>\n<li>Europe<\/li>\n<li>Asia Pacific<\/li>\n<li>Rest of the World<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p>The report includes detailed transcripts of discussions held with the following senior level representatives of stakeholder companies:<\/p>\n<ul>\n<li>Antonella Mancuso (Vice President and Chief Operating Officer, BSP Pharmaceuticals) and Maria Elena Guadagno (Business Director, BSP Pharmaceuticals)<\/li>\n<li>Klaus Hellerbrand (Managing Director, ProJect Pharmaceutics)<\/li>\n<li>Kevin Rosenthal (Business Head, Formulations and Finished Products, Alphora Research)<\/li>\n<li>Jennifer L Mitcham (Director, Business Development, Catalent Pharma Solutions) and Stacy McDonald (Group Product Manager, Catalent Pharma Solutions)<\/li>\n<li>Roberto Margarita (Business Development Director, CordenPharma)<\/li>\n<li>Allison Vavala (Senior Manager, Business Development, Helsinn)<\/li>\n<li>Mark Wright (Site Head, Piramal Healthcare)<\/li>\n<li>Javier E. Azn&aacute;rez Araiz (Business Development Technician, Idifarma)<\/li>\n<\/ul>\n<p>Ke companies covered in the report<\/p>\n<ul>\n<li>AbbVie Contract Manufacturing<\/li>\n<li>CARBOGEN AMCIS<\/li>\n<li>Catalent<\/li>\n<li>Evonik<\/li>\n<li>Formosa Laboratories<\/li>\n<li>Intas<\/li>\n<li>Lonza<\/li>\n<li>MabPlex<\/li>\n<li>Pfizer CentreOne<\/li>\n<\/ul>\n<p>For more information please click on the following link:<\/p>\n<p><a href=\"https:\/\/www.rootsanalysis.com\/reports\/view_document\/hpapi-and-cytotoxic-drugs-manufacturing\/299.html\">https:\/\/www.rootsanalysis.com\/reports\/view_document\/hpapi-and-cytotoxic-drugs-manufacturing\/299.html<\/a> &nbsp;<\/p>\n<p><strong>Other Recent Offerings<\/strong><\/p>\n<ol>\n<li><a href=\"https:\/\/www.rootsanalysis.com\/reports\/view_document\/antibody-cmo-market\/295.html\">Antibody Contract Manufacturing Market<\/a>, 2020 &ndash; 2030<\/li>\n<li><a href=\"https:\/\/www.rootsanalysis.com\/reports\/view_document\/cell-therapy-manufacturing\/285.html\">Cell Therapy Manufacturing Market<\/a> (3rd Edition), 2019 &ndash; 2030<\/li>\n<li><a href=\"https:\/\/www.rootsanalysis.com\/reports\/view_document\/biopharma-contract-manufacturing-market-3rd-edition-2019-2030\/250.html\">Biopharma Contract Manufacturing Market<\/a> (3rd Edition), 2019 &ndash; 2030<\/li>\n<\/ol>\n<p><strong>About Roots Analysis<\/strong><\/p>\n<p>Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you&rsquo;d like help with your growing business needs, get in touch at info@rootsanalysis.com<\/p>\n<p class=\"tags\">Tags: <a href=\"https:\/\/icrowdnewswire.com\/tag\/hpapi\/\" rel=\"tag\">HPAPI<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/manufacturing\/\" rel=\"tag\">manufacturing<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/drugs\/\" rel=\"tag\">drugs<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/report\/\" rel=\"tag\">report<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/rootsanalysis\/\" rel=\"tag\">Rootsanalysis<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/cytotoxic\/\" rel=\"tag\">cytotoxic<\/a> <\/p>\n<div><strong>See Campaign: <\/strong><a href=\"https:\/\/www.rootsanalysis.com\/reports\/view_document\/hpapi-and-cytotoxic-drugs-manufacturing\/299.html\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/www.rootsanalysis.com\/reports\/view_document\/hpapi-and-cytotoxic-drugs-manufacturing\/299.html<\/a><br \/><b>Contact Information:<\/b><br \/>Gaurav Chaudhary gaurav.chaudhary@rootsanalysis.com Roots Analysis A430, 4th Floor, Bestech Business Towers, Sector 66, Mohali, India sales@rootsanalysis.com +1 (415) 800 3415 +44 (122) 391 1091 Web: https:\/\/www.rootsanalysis.com\/ LinkedIn: https:\/\/in.linkedin.com\/company\/roots-analysis Twitter: https:\/\/twitter.com\/RootsAnalysis<\/p>\n<p><b>Tags:<\/b><br \/><a href=\"\"><\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/ips\/\" rel=\"category tag\">IPS<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/reportedtimes\/\" rel=\"category tag\">Reportedtimes<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/news-category\/extended-distribution\/\" rel=\"category tag\">Extended Distribution<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/news-category\/wire\/\" rel=\"category tag\">Wire<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/news-category\/research-newswire\/\" rel=\"category tag\">Research Newswire<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/language\/english\/\" rel=\"category tag\">English<\/a><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"\" alt=\"image\" width=\"400\" height=\"300\" class=\"cwdfimg\" \/><\/div>\n<div>\n<h3>Contact Information:<\/h3>\n<p>Gaurav Chaudhary<br \/> gaurav.chaudhary@rootsanalysis.com<br \/> Roots Analysis<br \/> A430, 4th Floor,<br \/> Bestech Business Towers, Sector 66, Mohali, India<br \/> sales@rootsanalysis.com<br \/> +1 (415) 800 3415<br \/> +44 (122) 391 1091<br \/> Web: https:\/\/www.rootsanalysis.com\/<br \/> LinkedIn: https:\/\/in.linkedin.com\/company\/roots-analysis<br \/> Twitter: https:\/\/twitter.com\/RootsAnalysis<\/p>\n<\/p>\n<\/div>\n<p>The post <a rel=\"nofollow\" href=\"https:\/\/heymuse.com\/growing-at-an-annualized-rate-of-12-the-hpapi-and-cytotoxic-drugs-contract-manufacturing-market-is-projected-to-reach-usd-25-billion-by-2030-claims-roots-analysis\/\">Growing at an annualized rate of 12%, the HPAPI and cytotoxic drugs contract manufacturing market is projected to reach USD 25 billion by 2030, claims Roots Analysis<\/a> appeared first on <a rel=\"nofollow\" href=\"https:\/\/heymuse.com\">Financial Market Brief<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Manufacturing highly potent drug products is technically and financially demanding; as a result, drug manufacturers are becoming increasingly reliant on contract service providers Roots Analysis is pleased to announce the publication of its recent study, titled, &ldquo;HPAPI and Cytotoxic Drugs Manufacturing (3rd Edition) 2020-2030.&rdquo; The report features an extensive study of the current market landscape [&hellip;]<\/p>\n<p>The post <a rel=\"nofollow\" href=\"https:\/\/heymuse.com\/growing-at-an-annualized-rate-of-12-the-hpapi-and-cytotoxic-drugs-contract-manufacturing-market-is-projected-to-reach-usd-25-billion-by-2030-claims-roots-analysis\/\">Growing at an annualized rate of 12%, the HPAPI and cytotoxic drugs contract manufacturing market is projected to reach USD 25 billion by 2030, claims Roots Analysis<\/a> appeared first on <a rel=\"nofollow\" href=\"https:\/\/heymuse.com\/\">Financial Market Brief<\/a>.<\/p>\n<p> <a href=\"http:\/\/ipsnews.net\/business\/2021\/04\/14\/growing-at-an-annualized-rate-of-12-the-hpapi-and-cytotoxic-drugs-contract-manufacturing-market-is-projected-to-reach-usd-25-billion-by-2030-claims-roots-analysis-3\/\" class=\"more-link\">Continue Reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":291,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20],"tags":[],"class_list":["post-111545","post","type-post","status-publish","format-standard","hentry","category-press-release"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Growing at an annualized rate of 12%, the HPAPI and cytotoxic drugs contract manufacturing market is projected to reach USD 25 billion by 2030, claims Roots Analysis - Business<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"http:\/\/ipsnews.net\/business\/2021\/04\/14\/growing-at-an-annualized-rate-of-12-the-hpapi-and-cytotoxic-drugs-contract-manufacturing-market-is-projected-to-reach-usd-25-billion-by-2030-claims-roots-analysis-3\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Growing at an annualized rate of 12%, the HPAPI and cytotoxic drugs contract manufacturing market is projected to reach USD 25 billion by 2030, claims Roots Analysis - Business\" \/>\n<meta property=\"og:description\" content=\"Manufacturing highly potent drug products is technically and financially demanding; as a result, drug manufacturers are becoming increasingly reliant on contract service providers Roots Analysis is pleased to announce the publication of its recent study, titled, &ldquo;HPAPI and Cytotoxic Drugs Manufacturing (3rd Edition) 2020-2030.&rdquo; The report features an extensive study of the current market landscape [&hellip;] The post Growing at an annualized rate of 12%, the HPAPI and cytotoxic drugs contract manufacturing market is projected to reach USD 25 billion by 2030, claims Roots Analysis appeared first on Financial Market Brief. Continue Reading &rarr;\" \/>\n<meta property=\"og:url\" content=\"http:\/\/ipsnews.net\/business\/2021\/04\/14\/growing-at-an-annualized-rate-of-12-the-hpapi-and-cytotoxic-drugs-contract-manufacturing-market-is-projected-to-reach-usd-25-billion-by-2030-claims-roots-analysis-3\/\" \/>\n<meta property=\"og:site_name\" content=\"Business\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-14T09:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/03\/4671-2693955i1UqqvJa.png\" \/>\n<meta name=\"author\" content=\"iCrowdNewswire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"iCrowdNewswire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"http:\/\/ipsnews.net\/business\/2021\/04\/14\/growing-at-an-annualized-rate-of-12-the-hpapi-and-cytotoxic-drugs-contract-manufacturing-market-is-projected-to-reach-usd-25-billion-by-2030-claims-roots-analysis-3\/\",\"url\":\"http:\/\/ipsnews.net\/business\/2021\/04\/14\/growing-at-an-annualized-rate-of-12-the-hpapi-and-cytotoxic-drugs-contract-manufacturing-market-is-projected-to-reach-usd-25-billion-by-2030-claims-roots-analysis-3\/\",\"name\":\"Growing at an annualized rate of 12%, the HPAPI and cytotoxic drugs contract manufacturing market is projected to reach USD 25 billion by 2030, claims Roots Analysis - Business\",\"isPartOf\":{\"@id\":\"https:\/\/ipsnews.net\/business\/#website\"},\"primaryImageOfPage\":{\"@id\":\"http:\/\/ipsnews.net\/business\/2021\/04\/14\/growing-at-an-annualized-rate-of-12-the-hpapi-and-cytotoxic-drugs-contract-manufacturing-market-is-projected-to-reach-usd-25-billion-by-2030-claims-roots-analysis-3\/#primaryimage\"},\"image\":{\"@id\":\"http:\/\/ipsnews.net\/business\/2021\/04\/14\/growing-at-an-annualized-rate-of-12-the-hpapi-and-cytotoxic-drugs-contract-manufacturing-market-is-projected-to-reach-usd-25-billion-by-2030-claims-roots-analysis-3\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/03\/4671-2693955i1UqqvJa.png\",\"datePublished\":\"2021-04-14T09:00:00+00:00\",\"author\":{\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/bde271d5882ffdcb71d1a2a961b51fee\"},\"breadcrumb\":{\"@id\":\"http:\/\/ipsnews.net\/business\/2021\/04\/14\/growing-at-an-annualized-rate-of-12-the-hpapi-and-cytotoxic-drugs-contract-manufacturing-market-is-projected-to-reach-usd-25-billion-by-2030-claims-roots-analysis-3\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"http:\/\/ipsnews.net\/business\/2021\/04\/14\/growing-at-an-annualized-rate-of-12-the-hpapi-and-cytotoxic-drugs-contract-manufacturing-market-is-projected-to-reach-usd-25-billion-by-2030-claims-roots-analysis-3\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"http:\/\/ipsnews.net\/business\/2021\/04\/14\/growing-at-an-annualized-rate-of-12-the-hpapi-and-cytotoxic-drugs-contract-manufacturing-market-is-projected-to-reach-usd-25-billion-by-2030-claims-roots-analysis-3\/#primaryimage\",\"url\":\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/03\/4671-2693955i1UqqvJa.png\",\"contentUrl\":\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/03\/4671-2693955i1UqqvJa.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"http:\/\/ipsnews.net\/business\/2021\/04\/14\/growing-at-an-annualized-rate-of-12-the-hpapi-and-cytotoxic-drugs-contract-manufacturing-market-is-projected-to-reach-usd-25-billion-by-2030-claims-roots-analysis-3\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ipsnews.net\/business\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Growing at an annualized rate of 12%, the HPAPI and cytotoxic drugs contract manufacturing market is projected to reach USD 25 billion by 2030, claims Roots Analysis\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ipsnews.net\/business\/#website\",\"url\":\"https:\/\/ipsnews.net\/business\/\",\"name\":\"Business\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ipsnews.net\/business\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/bde271d5882ffdcb71d1a2a961b51fee\",\"name\":\"iCrowdNewswire\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/aa079ec4d87ad6117c9db7a1a2cde1607ee2f869010252c2d0af346f0047b325?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/aa079ec4d87ad6117c9db7a1a2cde1607ee2f869010252c2d0af346f0047b325?s=96&d=mm&r=g\",\"caption\":\"iCrowdNewswire\"},\"sameAs\":[\"https:\/\/heymuse.com\/ips\"],\"url\":\"http:\/\/ipsnews.net\/business\/author\/icrowdnewswire\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Growing at an annualized rate of 12%, the HPAPI and cytotoxic drugs contract manufacturing market is projected to reach USD 25 billion by 2030, claims Roots Analysis - Business","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"http:\/\/ipsnews.net\/business\/2021\/04\/14\/growing-at-an-annualized-rate-of-12-the-hpapi-and-cytotoxic-drugs-contract-manufacturing-market-is-projected-to-reach-usd-25-billion-by-2030-claims-roots-analysis-3\/","og_locale":"en_US","og_type":"article","og_title":"Growing at an annualized rate of 12%, the HPAPI and cytotoxic drugs contract manufacturing market is projected to reach USD 25 billion by 2030, claims Roots Analysis - Business","og_description":"Manufacturing highly potent drug products is technically and financially demanding; as a result, drug manufacturers are becoming increasingly reliant on contract service providers Roots Analysis is pleased to announce the publication of its recent study, titled, &ldquo;HPAPI and Cytotoxic Drugs Manufacturing (3rd Edition) 2020-2030.&rdquo; The report features an extensive study of the current market landscape [&hellip;] The post Growing at an annualized rate of 12%, the HPAPI and cytotoxic drugs contract manufacturing market is projected to reach USD 25 billion by 2030, claims Roots Analysis appeared first on Financial Market Brief. Continue Reading &rarr;","og_url":"http:\/\/ipsnews.net\/business\/2021\/04\/14\/growing-at-an-annualized-rate-of-12-the-hpapi-and-cytotoxic-drugs-contract-manufacturing-market-is-projected-to-reach-usd-25-billion-by-2030-claims-roots-analysis-3\/","og_site_name":"Business","article_published_time":"2021-04-14T09:00:00+00:00","og_image":[{"url":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/03\/4671-2693955i1UqqvJa.png","type":"","width":"","height":""}],"author":"iCrowdNewswire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"iCrowdNewswire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"http:\/\/ipsnews.net\/business\/2021\/04\/14\/growing-at-an-annualized-rate-of-12-the-hpapi-and-cytotoxic-drugs-contract-manufacturing-market-is-projected-to-reach-usd-25-billion-by-2030-claims-roots-analysis-3\/","url":"http:\/\/ipsnews.net\/business\/2021\/04\/14\/growing-at-an-annualized-rate-of-12-the-hpapi-and-cytotoxic-drugs-contract-manufacturing-market-is-projected-to-reach-usd-25-billion-by-2030-claims-roots-analysis-3\/","name":"Growing at an annualized rate of 12%, the HPAPI and cytotoxic drugs contract manufacturing market is projected to reach USD 25 billion by 2030, claims Roots Analysis - Business","isPartOf":{"@id":"https:\/\/ipsnews.net\/business\/#website"},"primaryImageOfPage":{"@id":"http:\/\/ipsnews.net\/business\/2021\/04\/14\/growing-at-an-annualized-rate-of-12-the-hpapi-and-cytotoxic-drugs-contract-manufacturing-market-is-projected-to-reach-usd-25-billion-by-2030-claims-roots-analysis-3\/#primaryimage"},"image":{"@id":"http:\/\/ipsnews.net\/business\/2021\/04\/14\/growing-at-an-annualized-rate-of-12-the-hpapi-and-cytotoxic-drugs-contract-manufacturing-market-is-projected-to-reach-usd-25-billion-by-2030-claims-roots-analysis-3\/#primaryimage"},"thumbnailUrl":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/03\/4671-2693955i1UqqvJa.png","datePublished":"2021-04-14T09:00:00+00:00","author":{"@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/bde271d5882ffdcb71d1a2a961b51fee"},"breadcrumb":{"@id":"http:\/\/ipsnews.net\/business\/2021\/04\/14\/growing-at-an-annualized-rate-of-12-the-hpapi-and-cytotoxic-drugs-contract-manufacturing-market-is-projected-to-reach-usd-25-billion-by-2030-claims-roots-analysis-3\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["http:\/\/ipsnews.net\/business\/2021\/04\/14\/growing-at-an-annualized-rate-of-12-the-hpapi-and-cytotoxic-drugs-contract-manufacturing-market-is-projected-to-reach-usd-25-billion-by-2030-claims-roots-analysis-3\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"http:\/\/ipsnews.net\/business\/2021\/04\/14\/growing-at-an-annualized-rate-of-12-the-hpapi-and-cytotoxic-drugs-contract-manufacturing-market-is-projected-to-reach-usd-25-billion-by-2030-claims-roots-analysis-3\/#primaryimage","url":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/03\/4671-2693955i1UqqvJa.png","contentUrl":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/03\/4671-2693955i1UqqvJa.png"},{"@type":"BreadcrumbList","@id":"http:\/\/ipsnews.net\/business\/2021\/04\/14\/growing-at-an-annualized-rate-of-12-the-hpapi-and-cytotoxic-drugs-contract-manufacturing-market-is-projected-to-reach-usd-25-billion-by-2030-claims-roots-analysis-3\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ipsnews.net\/business\/"},{"@type":"ListItem","position":2,"name":"Growing at an annualized rate of 12%, the HPAPI and cytotoxic drugs contract manufacturing market is projected to reach USD 25 billion by 2030, claims Roots Analysis"}]},{"@type":"WebSite","@id":"https:\/\/ipsnews.net\/business\/#website","url":"https:\/\/ipsnews.net\/business\/","name":"Business","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ipsnews.net\/business\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/bde271d5882ffdcb71d1a2a961b51fee","name":"iCrowdNewswire","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/aa079ec4d87ad6117c9db7a1a2cde1607ee2f869010252c2d0af346f0047b325?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/aa079ec4d87ad6117c9db7a1a2cde1607ee2f869010252c2d0af346f0047b325?s=96&d=mm&r=g","caption":"iCrowdNewswire"},"sameAs":["https:\/\/heymuse.com\/ips"],"url":"http:\/\/ipsnews.net\/business\/author\/icrowdnewswire\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"http:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/111545","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/users\/291"}],"replies":[{"embeddable":true,"href":"http:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/comments?post=111545"}],"version-history":[{"count":1,"href":"http:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/111545\/revisions"}],"predecessor-version":[{"id":111546,"href":"http:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/111545\/revisions\/111546"}],"wp:attachment":[{"href":"http:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/media?parent=111545"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/categories?post=111545"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/tags?post=111545"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}